Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
223.00    0.40 (0.18%)
Bid:
222.40
Ask:
222.80
Spread: 0.40 (0.18%)
Market Cap: £2.28b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Conditional Redemption of Senior Notes

20 May 2024 08:15

RNS Number : 0664P
Helios Towers PLC
20 May 2024
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

NOT FOR DISTRIBUTION IN OR INTO ANY JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

 

HELIOS TOWERS ANNOUNCES CONDITIONAL NOTICE OF REDEMPTION FOR ALL OF ITS OUTSTANDING 7.000% SENIOR NOTES DUE 2025

May 20, 2024 - HTA Group, Ltd (the "Issuer"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces it has issued a conditional notice of redemption for all of its outstanding 7.000% Senior Notes due 2025 (the "Notes"). As set forth in the conditional notice of redemption issued today in respect of the Notes, the redemption date is June 18, 2024 (the "Redemption Date") unless the Redemption Date is delayed or revoked by the Issuer, and the redemption price for the Notes is 100.000% of the principal amount thereof, plus the amount of accrued and unpaid interest to, but excluding, the Redemption Date.

On the date hereof, the Issuer also announced (i) its offer to purchase for cash any and all of the Notes (the "Tender Offer") and (ii) an offering of new U.S. dollar-denominated senior notes subject to market conditions (the "New Notes Offering"). Any notes issued pursuant to the New Notes Offering and the guarantees in respect thereof have not been and will not be registered under the United States Securities Act of 1933. Neither the Tender Offer nor this announcement is an offer to sell or a solicitation of an offer to buy any notes issued pursuant to the New Notes Offering. No action has been or will be taken in any jurisdiction in relation to any notes issued pursuant to the New Notes Offering to permit a public offering of securities. This notice does not constitute an offer to sell, or a solicitation of an offer to buy, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation or sale would be unlawful.

The redemption is subject to and conditioned upon the successful completion (in the sole determination of the Issuer) of the New Notes Offering.

Forward-Looking Information

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Issuer concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Issuer and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

These forward-looking statements speak only as of the date of this announcement. The Issuer does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQBLBLZELXBBE
Date   Source Headline
6th Oct 20259:15 amRNSHolding(s) in Company
3rd Oct 20257:04 amRNSHolding(s) in Company
1st Oct 20257:00 amRNSResults of convertible bond tender
30th Sep 20255:27 pmRNSLaunch of convertible bond tender
19th Sep 20252:56 pmRNSDirector/PDMR Shareholding
18th Sep 20259:34 amRNSHolding(s) in Company
15th Sep 20252:36 pmRNSHelios Towers_TR1_Notification FCA Submitted
11th Sep 20257:00 amRNSAppointment of Corporate Broker
21st Aug 202511:17 amRNSDirector Declaration
31st Jul 20257:00 amRNSH1 2025 Results
3rd Jul 20257:00 amRNSNotice of H1 2025 Results Date & Conference Call
1st Jul 20259:41 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSBlock Listing Application
23rd Jun 20251:27 pmRNSHolding(s) in Company
18th Jun 20251:16 pmRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSChange of Director Responsibilities
15th May 20253:32 pmRNS2025 Annual General Meeting Results
9th May 20254:35 pmRNSHolding(s) in Company
8th May 20257:00 amRNSQ1 2025 Results
6th May 20258:30 amRNSBlock Listing Six Monthly Return
9th Apr 20257:00 amRNSNotice of Q1 2025 Results Date & Conference Call
8th Apr 20258:36 amRNSHolding(s) in Company
8th Apr 20258:32 amRNSHolding(s) in Company
7th Apr 202510:18 amRNSAnnual Report and Notice of AGM
31st Mar 20259:45 amRNSTotal Voting Rights
28th Mar 20256:19 pmRNSHolding(s) in Company
17th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20254:36 pmRNSNotification of Major Holdings
4th Feb 20259:18 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of FY 2024 Results Date & Conference Call
8th Jan 20257:00 amRNSHolding(s) in Company
6th Jan 20252:33 pmRNSChange to a Director’s Role and Responsibilities
19th Dec 202410:53 amRNSDirector/PDMR Shareholding
9th Dec 202411:02 amRNSDirector/PDMR Shareholding
26th Nov 20249:09 amRNSHolding(s) in Company
22nd Nov 20247:00 amRNSHolding(s) in Company
20th Nov 202410:07 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
19th Nov 20244:47 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
19th Nov 20243:40 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSQ3 2024 Results
4th Nov 20247:00 amRNSBlock Listing Six Monthly Return
8th Oct 20247:00 amRNSNotice of Q3 2024 Results Date & Conference Call
30th Sep 20241:04 pmRNSHolding(s) in Company
16th Sep 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSHalf-year Report
3rd Jul 20247:00 amRNSNotice of H1 2024 Results Date & Conference Call
20th Jun 20246:02 pmRNSHolding(s) in Company
20th Jun 20243:24 pmRNSDirector/PDMR Shareholding
19th Jun 20245:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.